AGP Picks
View all

Technology Wire Cambodia
Provided by AGP

Technology Wire Cambodia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 21, 2026

Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
26 minutes ago

Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development

Indeterminate GlobeNewswire
BellSoft Announces Hardened Builder for Paketo Buildpacks™, Bringing Zero-CVE Container Images to Buildpacks® Users
26 minutes ago

BellSoft Announces Hardened Builder for Paketo Buildpacks™, Bringing Zero-CVE Container Images to Buildpacks® Users

Indeterminate GlobeNewswire
Altia Launches Altia AI, an Intelligent Layer That Helps HMI Teams Build, Debug and Optimize Faster Without Compromising Production Code
26 minutes ago

Altia Launches Altia AI, an Intelligent Layer That Helps HMI Teams Build, Debug and Optimize Faster Without Compromising Production Code

Indeterminate GlobeNewswire
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
26 minutes ago

Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries

Indeterminate GlobeNewswire
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
36 minutes ago

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Indeterminate GlobeNewswire
ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement
41 minutes ago

ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement

Indeterminate GlobeNewswire
Correction: Agentic Day Lands in Toronto, Completing a Three-Country, Two-Continent 2026 Series
42 minutes ago

Correction: Agentic Day Lands in Toronto, Completing a Three-Country, Two-Continent 2026 Series

Indeterminate GlobeNewswire
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
an hour ago

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly

Indeterminate GlobeNewswire
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
an hour ago

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

Indeterminate GlobeNewswire
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
an hour ago

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Indeterminate GlobeNewswire
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
an hour ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Indeterminate GlobeNewswire
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
an hour ago

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Indeterminate GlobeNewswire
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
an hour ago

Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®

Indeterminate GlobeNewswire
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
an hour ago

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
an hour ago

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Indeterminate GlobeNewswire
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
an hour ago

Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types

Indeterminate GlobeNewswire
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
an hour ago

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication
an hour ago

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Indeterminate GlobeNewswire
Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange
an hour ago

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

Indeterminate GlobeNewswire
R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis
an hour ago

R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Wire Cambodia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.